Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)

Hong Kong · Delayed Price · Currency is HKD

20.46

-0.04 (-0.20%)

Mar 4, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Sales of Neurovascular and Peripheral-Vascular Interventional Surgical Devices	782.48M	527.75M	334.09M	177.91M	27.63M
Sales of Neurovascular and Peripheral-Vascular Interventional Surgical Devices Growth	48.27%	57.97%	87.78%	543.89%	461.95%
Total	782.48M	527.75M	334.09M	177.91M	27.63M
Total Growth	48.27%	57.97%	87.78%	543.89%	461.95%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
The PRC	759.90M	513.48M	326.29M	174.45M	24.28M
The PRC Growth	47.99%	57.37%	87.04%	618.37%	3344.54%
Others	22.58M	14.27M	7.80M	3.46M	3.35M
Others Growth	58.19%	83.07%	125.19%	3.44%	-20.54%
Total	782.48M	527.75M	334.09M	177.91M	27.63M
Total Growth	48.27%	57.97%	87.78%	543.89%	461.95%

Source: S&P Global Market Intelligence.